GSGSK GSK · NYSE
$51.05 -0.10% (-$0.05)
- Market cap
- £76.7B
- Enterprise value
- £91.8B
- P/E
- 15.9x
- Forward P/E
- 10.3x
- PEG
- 0.1x
- P/S
- 2.3x
- P/FCF
- 11.0x
- EV/EBITDA
- 8.4x
- ROIC
- 13.9%
- Bruto marža
- 72.7%
- Neto marža
- 14.5%
- Dividend yield
- 3.57%
- Payout ratio
- 56.8%
- Neto dolg/EBITDA
- 1.4x
- Beta
- 0.28
- Free float
- 96.9%
O podjetju
GSK plc is a global pharmaceutical company with a long history and a wide portfolio of medicinal products. The company specializes in researching, developing, and manufacturing drugs for various therapeutic areas, including infectious diseases, respiratory conditions, oncology, immunology, and others. GSK is known for its iconic products and vaccines that help fight diseases worldwide. The company collaborates with research institutions and partners around the world to innovate in the field of medicines and provide new and effective treatment solutions. GSK is also actively working on the development of new vaccines and drugs, including vaccines for COVID-19. GSK plc (GSK) shares may be an interesting choice for investors who follow the pharmaceutical industry and seek investment opportunities in a long-established company with innovative research and a wide portfolio of medicinal products.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Luke Victor Miels
Employees
66,841
Headquarters
London
Vrednotenje
Je današnja cena primerna?
- Kaj govori v prid: Za 1 GBP letnega dobička plačate 15,9 GBP, malo za njen sektor.
Rast in ocene
Ali podjetje raste in kaj sledi?
- Na kaj bodite pozorni: Dobiček na delnico je v zadnjih 3 letih padal za 8,8 % letno.
- Na kaj bodite pozorni: Dobiček na delnico iz leta v leto močno niha.
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
- Kaj govori v prid: Od vsakih 100 GBP prihodkov ostane 15 GBP čistega dobička.
- Kaj govori v prid: Na vsakih 100 GBP vloženega kapitala zasluži 14 GBP letno.
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke